BRIEF-Orbimed Advisors acquired 480,000 common shares of Cynapsus Therapeutics

Thu Jul 7, 2016 7:16am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

July 7 (Reuters) - Orbimed Advisors Llc

* Acquired 480,000 common shares of cynapsus therapeutics inc

* Now collectively beneficially owns, controls and directs more than 10% of outstanding common shares of cynapsus

* Common shares were acquired at a price of us$13.00 per common share for total consideration paid of us$6.3 million Source text for Eikon: Further company coverage: )